Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: MENSO who wrote (1529)	6/13/2007 8:05:37 PM
From: MENSO	Read Replies (1) \| Respond to of 1533

ONCONASE INDUCES CELL DEATH IN CHEMORESISTANT NEUROBLASTOMA CELLS ONCONASE INDUCES CASPASE-INDEPENDENT CELL DEATH IN CHEMORESISTANT NEUROBLASTOMA CELLS according to researches. The findings, awesome news for patients and ACEL investors alike, were presented at an Oncology conference last Sunday June 9, 2007. The details of their research I will defer to Alfacell to release in the coming days. A brief summary of the program, the researcher names, and the title they chose for their presentation follow, for the pleasurable late-evening reading of some - and the nightmares of others: WHERE: Zentrum für Frauen- Kinder- und Jugendmedizin Klinik für pädiatische Hämatologie und Onkologie XX. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung in Wilsede vom 6. - 9. Juni 2007 WHEN: Sonnabend, 9. Juni 2007 09:00 - 10:30 Uhr PRESENTATION TITLE: 15.e Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells RESEARCHERS: F Rothweiler, M Michaelis, J Cinatl, P Anand, R Kotchetkov, A von Deimling, HW Doerr, K Shogen, J Cinatl jr.